Graduates to the OTCQX Best Market VANCOUVER, BC, Jan. 26, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it will commence trading on the OTCQX® Best Market in the United States when the market opens tomorrow, Thursday, January 27, 2022. Numinus' shares previously traded on the Pink market and will continue to trade under the symbol "NUMIF."
The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Trading on the OTCQX will provide greater visibility and accessibility of Numinus in the U.S.
"Graduating to the OTCQX is a first step towards further accessing U.S. based investors," stated Payton Nyquvest, Founder and CEO. "As we grow our network of Numinus Health wellness clinics to include locations in the U.S. – and build a stronger brand presence in this important market – we will also look to establish an even greater profile with the U.S. investment community."
U.S. investors or other interested parties can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
About Numinus
Numinus Wellness (TSX: NUMI;OTCQX: NUMIF) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.